Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420]
A. John Camm,Paulus Kirchhof,Gregory Y.H. Lip,Ulrich Schotten,Irene Savelieva,Sabine Ernst,Isabelle C. Van Gelder,Nawwar Al-Attar,Gerhard Hindricks,Bernard Prendergast,Hein Heidbuchel,Ottavio Alfieri,Annalisa Angelini,Dan Atar,Paolo Colonna,Raffaele De Caterina,Johan De Sutter,Andreas Goette,Bulent Gorenek,Magnus Heldal,Stefan H. Hohloser,Philippe Kolh,Jean-Yves Le Heuzey,Piotr Ponikowski,Frans H. Rutten +24 more
Reads0
Chats0
TLDR
The European Society of Cardiology and the publishers regret that a table containing errors was published in these guidelines.Abstract:
The European Society of Cardiology and the publishers regret that a table containing errors was published in these guidelines. Table 15 (page 2399 in …read more
Citations
More filters
Journal ArticleDOI
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
A. Pieter Kappetein,Stuart J. Head,Philippe Généreux,Nicolo Piazza,Nicolas M. Van Mieghem,Eugene H. Blackstone,Thomas G. Brott,David J. Cohen,Donald E. Cutlip,Gerrit Anne van Es,Rebecca T. Hahn,Ajay J. Kirtane,Mitchell W. Krucoff,Susheel Kodali,Michael J. Mack,Roxana Mehran,Josep Rodés-Cabau,Pascal Vranckx,John G. Webb,Stephan Windecker,Patrick W. Serruys,Martin B. Leon +21 more
TL;DR: This VARC-2 document has provided further standardization of endpoint definitions for studies evaluating the use of TAVI, which will lead to improved comparability and interpretability of the study results, supplying an increasingly growing body of evidence with respect to TAVi and/or surgical aortic valve replacement.
Journal ArticleDOI
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Willem Dewilde,Tom Oirbans,Freek W.A. Verheugt,Johannes C. Kelder,Bart J.G.L. de Smet,Jean-Paul R. Herrman,Tom Adriaenssens,Mathias Vrolix,A. A. C. M. Heestermans,Marije M. Vis,Jan G. P. Tijsen,Arnoud W. van 't Hof,Jurriën M. ten Berg +12 more
TL;DR: Use of clopiogrel without aspirin was associated with a significant reduction in bleeding complications and no increase in the rate of thrombotic events.
Journal ArticleDOI
Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation The DECAAF Study
Nassir F. Marrouche,David J. Wilber,Gerhard Hindricks,Pierre Jaïs,Nazem Akoum,Francis E. Marchlinski,Eugene G. Kholmovski,Nathan S. Burgon,Nan Hu,Lluís Mont,Thomas Deneke,Mattias Duytschaever,Thomas Neumann,Moussa Mansour,Christian Mahnkopf,Bengt Herweg,Emile G. Daoud,Erik Wissner,Paul M. Bansmann,Johannes Brachmann +19 more
TL;DR: Among patients with AF undergoing catheter ablation, atrial tissue fibrosis estimated by delayed enhancement MRI was independently associated with likelihood of recurrent arrhythmia and the clinical implications of this association warrant further investigation.
Journal ArticleDOI
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel,Peter Verhamme,Marco Alings,Matthias Antz,Werner Hacke,Jonas Oldgren,Peter Sinnaeve,A. John Camm,Paulus Kirchhof,Paulus Kirchhof +9 more
TL;DR: New oral anticoagulant drugs are an alternative for vitamin K antagonists to prevent stroke in patients with non-valvular atrial fibrillation (AF) and many unresolved questions on how to optimally use these drugs in specific clinical situations remain.
Journal ArticleDOI
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
Allan C. Skanes,Jeff S. Healey,John A. Cairns,Paul Dorian,Anne M. Gillis,M. Sean McMurtry,L. Brent Mitchell,Atul Verma,Stanley Nattel +8 more
TL;DR: This report presents the details of the new recommendations, along with the background and rationale, for focused updating of the 2010 Guidelines with respect to stroke prevention and rate/rhythm control.